Latest filing published 07 Jun 2023 for Bellerophon Therapeutics, Inc., €104k.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Puissance Life Science Opportunities Fund VI: trading record in brief
This profile gathers the share dealings of Puissance Life Science Opportunities Fund VI in Bellerophon Therapeutics, Inc. The record holds 5 filings, for trades running from 21 May 2020 to 7 June 2023.
Every open-market trade on record is a sale: 2 sales worth €5.0M. Besides market trades, the filings include 3 share grants. Since January 2023: no purchases and 2 sales on the market.
The newest entry dates from 7 June 2023: an open-market sale of €104k, in Bellerophon Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Puissance Life Science Opportunities Fund VI
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 134,421 shares@ US$0.832.1% of flowCommon StockSEC:0001760460-23-000006:0
- 560,000 shares@ US$9.4696.9% of flowCommon StockSEC:0001760460-23-000003:0
- 8,189 shares@ US$4.000.5% of flowCommon StockSEC:0001760460-21-000004:0
3 of 3 declarations